Treatment Strategies In Patients With Uterine Myomas

Myomas, also referred to as fibroids, are a selected characteristic of the human species. No other primates develop fibroids. Myomas could be the worth our species pays for our bipedal and extremely smart existence. Traditionally, over 50% of all hysterectomies were performed for fibroids, resulting in a big healthcare burden. In this article, we review the developments of the past 20 years with reference to multiple new treatment strategies that have evolved during this point.   Myomas or fibroids are the foremost common benign tumour of the feminine genital system, and while many remain asymptomatic, their impact on individual well-being are often significant. Traditionally, myomas are the leading cause for hysterectomy, making this surgery the third commonest surgical intervention worldwide. Removal of the uterus, while offering a definitive solution to the matter of fibroids, is inacceptable to women desirous of (further) childbearing or to some women just because of psychological reasons. As a result, surgical myomectomy has been an alternate treatment option for over 100 years, originally by laparotomy and lately through minimal invasive techniques like laparoscopy or hysteroscopy. The first documented, and still available, article was published in 1887 by Dr. Thomas Keith within the British Medical Journal: “Results of Supravaginal Hysterectomy, with Remarks on the Old Way and therefore the New of Treating Uterine Fibroids”. It is a desirable article and may only be recommended as a humbling experience with reference to how slow medical progress can truly be. Also, in the second sentence of the article, a mortality of 7.1% is cited without much comment. Therefore, on the other hand, there has been a lot of improvement. Already the second available article within the English literature explores alternative treatment options.

High Impact List of Articles

Relevant Topics in General Science